aMBR Genomics
Madison, US · Founded 2025 · Delaware corporation
Founders & leadership
MM
Michael MoserinVP of Research and Development
AS
Ahna SkopNamed on SEC filing
EY
Eugene YeoNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2025
▶$1.1MraisedMar 2026 · 4 investors · Other Health CareRule 506(b)
▶$1.1MraisedMar 2026 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ahna SkopExecutive Officer, Director
- Michael MoserExecutive Officer
- Eugene YeoExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.1M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has aMBR Genomics raised?
- aMBR Genomics has disclosed $1.1M raised across 1 round.
- Where is aMBR Genomics headquartered?
- aMBR Genomics is headquartered in Madison, US.